M P Dierich|B Landen - JoVE Visualize

Showing results (181-190 of 339) with videos related to

Pageof 34

Sort By:

Mycoses|April 14, 2005

Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patientsCornelia Lass-Flörl, E Gunsilius, G Gastl, et al.

Molecular Immunology|April 1, 1995

HIV-1 rsgp41 depends on calcium for binding of human c1q but not for binding of gp120H Stoiber, C F Ebenbichler, N M Thielens, et al.

Immunology Letters|July 1, 1993

The human monocyte cell line U937 binds HIV-1 gp41 by proteins of 37, 45, 49, 62 and 92 kDaY H Chen, G Böck, R Vornhagen, et al.

Immunobiology|April 25, 2000

HIV-2 transmembrane protein gp36 binds to the putative cellular receptor proteins P45 and P62Y H Chen, Y Xiao, W Wu, et al.

Immunobiology|August 1, 1993

HIV-1 gp41 binding to human peripheral blood mononuclear cells occurs preferentially to B Lymphocytes and monocytesY H Chen, G Böck, R Vornhagen, et al.

The Journal of Experimental Medicine|August 1, 1974

Variation in susceptibility of a human lymphoid cell line to immune lysis during the cell cycle. Lack of correlation with antigen density and complement bindingM A Pellegrino, S Ferrone, N R Cooper, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1975

Distinction between malignant L cells and normal mouse fibroblasts by rosette formation with sheep red blood cellsJ A Hock, M P Dierich, M A Pellegrino, et al.

Molecular Immunology|September 1, 1994

HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II expression by gp41Y H Chen, G Böck, R Vornhagen, et al.

The Biochemical Journal|December 15, 1985

Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor HJ Alsenz, T F Schulz, J D Lambris, et al.

The Journal of Infectious Diseases|April 16, 1998

Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitroA Gruber, E Lukasser-Vogl, M Borg-von Zepelin, et al.

Pageof 34

Showing results (181-190 of 339) with videos related to

Sort By:

Pageof 34

Mycoses|April 14, 2005

Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patientsCornelia Lass-Flörl, E Gunsilius, G Gastl, et al.

Molecular Immunology|April 1, 1995

HIV-1 rsgp41 depends on calcium for binding of human c1q but not for binding of gp120H Stoiber, C F Ebenbichler, N M Thielens, et al.

Immunology Letters|July 1, 1993

The human monocyte cell line U937 binds HIV-1 gp41 by proteins of 37, 45, 49, 62 and 92 kDaY H Chen, G Böck, R Vornhagen, et al.

Immunobiology|April 25, 2000

HIV-2 transmembrane protein gp36 binds to the putative cellular receptor proteins P45 and P62Y H Chen, Y Xiao, W Wu, et al.

Immunobiology|August 1, 1993

HIV-1 gp41 binding to human peripheral blood mononuclear cells occurs preferentially to B Lymphocytes and monocytesY H Chen, G Böck, R Vornhagen, et al.

The Journal of Experimental Medicine|August 1, 1974

Variation in susceptibility of a human lymphoid cell line to immune lysis during the cell cycle. Lack of correlation with antigen density and complement bindingM A Pellegrino, S Ferrone, N R Cooper, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1975

Distinction between malignant L cells and normal mouse fibroblasts by rosette formation with sheep red blood cellsJ A Hock, M P Dierich, M A Pellegrino, et al.

Molecular Immunology|September 1, 1994

HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II expression by gp41Y H Chen, G Böck, R Vornhagen, et al.

The Biochemical Journal|December 15, 1985

Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor HJ Alsenz, T F Schulz, J D Lambris, et al.

The Journal of Infectious Diseases|April 16, 1998

Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitroA Gruber, E Lukasser-Vogl, M Borg-von Zepelin, et al.

Pageof 34